Satter Muneer A
Director | Director, 10% Owner | See Remarks +2 more
5 companies
Insider Signal Score
58
GoodTrades Analyzed
8
12M Win Rate
33.3%
Avg 3M Return
+35.7%
Avg 12M Return
-3.5%
Satter Muneer A is a See Remarks at Rein Therapeutics, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 20 buys and 0 sells.
Estimated insider holdings value: $96.9M based on current market prices.
Holdings by Company
RNTXJan 8, 2021
Current Shares16.61M
Value$13.10M
Net Activity+12.73M
Bought: 12.73MSold: 0
ANNXNov 21, 2025
Current Shares9.73M
Value$54.48M
Net Activity+7.97M
Bought: 7.97MSold: 0
WHWKJan 10, 2019
Current Shares5.62M
Value$26.42M
Net Activity+3.50M
Bought: 3.50MSold: 0
AKBAJul 5, 2017
Current Shares3.04M
Value$2.90M
Net Activity+1.45M
Bought: 1.45MSold: 0
IMUXSep 17, 2018
Current Shares0
Value-
Net Activity-6,732,277
Bought: 4.65MSold: 11.38M
Transaction History
Showing 10 filings (page 3)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2018 | WHWK Whitehawk Therapeutics, Inc. | Director, 10% Owner | Buy | 13,000 | $4.97 | $64,585.02 | +0.2% | |
| Dec 13, 2017 | IMUX Immunic, Inc. | Director, 10% Owner | Buy | 100,000 | $5.48 | $548,335.00 | +0.4% | |
| Dec 11, 2017 | IMUX Immunic, Inc. | Director, 10% Owner | Buy | 150,000 | $4.89 | $733,140.00 | +0.4% | |
| Sep 14, 2017 | IMUX Immunic, Inc. | Director, 10% Owner | Buy | 130,000 | $4.01 | $521,229.00 | +0.4% | |
| Sep 8, 2017 | IMUX Immunic, Inc. | Director, 10% Owner | Buy | 50,000 | $3.53 | $176,615.00 | +0.5% | |
| Jul 5, 2017 | RNTX Rein Therapeutics, Inc. | 10% Owner | Buy | 33,333 | $15.00 | $499,995.00 | +23.0% | |
| Jul 5, 2017 | AKBA Akebia Therapeutics, Inc. | Director | Buy | 1,034,482 | $14.50 | $14,999,989.00 | +51.7% | |
| Jun 14, 2017 | IMUX Immunic, Inc. | Director, 10% Owner | Buy | 20,000 | $3.07 | $61,319.00 | - | |
| Jun 12, 2017 | IMUX Immunic, Inc. | Director, 10% Owner | Buy | 30,000 | $3.11 | $93,306.00 | - | |
| Jun 7, 2017 | IMUX Immunic, Inc. | Director, 10% Owner | Buy | 20,000 | $3.20 | $64,014.00 | - |